Cargando…

Serum free thiols in type 2 diabetes mellitus: A prospective study

AIMS: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflect...

Descripción completa

Detalles Bibliográficos
Autores principales: Schillern, Emmelien E.M., Pasch, Andreas, Feelisch, Martin, Waanders, Femke, Hendriks, Steven H., Mencke, Rik, Harms, Geert, Groenier, Klaas H., Bilo, Henk J.G., Hillebrands, Jan-Luuk, van Goor, Harry, van Dijk, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407140/
https://www.ncbi.nlm.nih.gov/pubmed/30899672
http://dx.doi.org/10.1016/j.jcte.2019.100182
_version_ 1783401479691829248
author Schillern, Emmelien E.M.
Pasch, Andreas
Feelisch, Martin
Waanders, Femke
Hendriks, Steven H.
Mencke, Rik
Harms, Geert
Groenier, Klaas H.
Bilo, Henk J.G.
Hillebrands, Jan-Luuk
van Goor, Harry
van Dijk, Peter R.
author_facet Schillern, Emmelien E.M.
Pasch, Andreas
Feelisch, Martin
Waanders, Femke
Hendriks, Steven H.
Mencke, Rik
Harms, Geert
Groenier, Klaas H.
Bilo, Henk J.G.
Hillebrands, Jan-Luuk
van Goor, Harry
van Dijk, Peter R.
author_sort Schillern, Emmelien E.M.
collection PubMed
description AIMS: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. METHODS: R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. RESULTS: In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell’s C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. CONCLUSIONS: Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM.
format Online
Article
Text
id pubmed-6407140
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64071402019-03-21 Serum free thiols in type 2 diabetes mellitus: A prospective study Schillern, Emmelien E.M. Pasch, Andreas Feelisch, Martin Waanders, Femke Hendriks, Steven H. Mencke, Rik Harms, Geert Groenier, Klaas H. Bilo, Henk J.G. Hillebrands, Jan-Luuk van Goor, Harry van Dijk, Peter R. J Clin Transl Endocrinol Research Paper AIMS: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. METHODS: R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. RESULTS: In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell’s C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. CONCLUSIONS: Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM. Elsevier 2019-02-28 /pmc/articles/PMC6407140/ /pubmed/30899672 http://dx.doi.org/10.1016/j.jcte.2019.100182 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Schillern, Emmelien E.M.
Pasch, Andreas
Feelisch, Martin
Waanders, Femke
Hendriks, Steven H.
Mencke, Rik
Harms, Geert
Groenier, Klaas H.
Bilo, Henk J.G.
Hillebrands, Jan-Luuk
van Goor, Harry
van Dijk, Peter R.
Serum free thiols in type 2 diabetes mellitus: A prospective study
title Serum free thiols in type 2 diabetes mellitus: A prospective study
title_full Serum free thiols in type 2 diabetes mellitus: A prospective study
title_fullStr Serum free thiols in type 2 diabetes mellitus: A prospective study
title_full_unstemmed Serum free thiols in type 2 diabetes mellitus: A prospective study
title_short Serum free thiols in type 2 diabetes mellitus: A prospective study
title_sort serum free thiols in type 2 diabetes mellitus: a prospective study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407140/
https://www.ncbi.nlm.nih.gov/pubmed/30899672
http://dx.doi.org/10.1016/j.jcte.2019.100182
work_keys_str_mv AT schillernemmelienem serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT paschandreas serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT feelischmartin serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT waandersfemke serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT hendriksstevenh serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT menckerik serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT harmsgeert serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT groenierklaash serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT bilohenkjg serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT hillebrandsjanluuk serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT vangoorharry serumfreethiolsintype2diabetesmellitusaprospectivestudy
AT vandijkpeterr serumfreethiolsintype2diabetesmellitusaprospectivestudy